FDA grants fast track designation to new glutaminase inhibitor CB-839 for metastatic kidney cancer
Calithera Biosciences announced yesterday that the FDA has granted fast [...]
Calithera Biosciences announced yesterday that the FDA has granted fast [...]
Two recent studies presented at the American Society of Clinical [...]
Drugs that target a protein called indoleamine 2,3-dioxygenase (or IDO [...]
An article in The Daily Mail last week reports on official NHS [...]
A recent study presented at the American Urology Association (AUA) [...]
A recent study presented at the American Urology Association (AUA) [...]
Results from the PROTECT clinical trial, a phase III trial [...]
The results of the IMmotion150 trial, a phase II trial looking [...]
Results from an early phase Ib clinical trial of avelumab [...]
The results from a phase II clinical trial, which demonstrates [...]